这是一篇来自已证抗体库的有关人类 DLC1的综述,是根据2篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合DLC1 抗体。
DLC1 同义词: ARHGAP7; STARD12; p122-RhoGAP; rho GTPase-activating protein 7; Rho-GTPase-activating protein 7; START domain-containing protein 12; StAR-related lipid transfer (START) domain containing 12; deleted in liver cancer 1 protein; deleted in liver cancer 1 variant 2; deleted in liver cancer variant 4; rho-type GTPase-activating protein 7

圣克鲁斯生物技术
小鼠 单克隆(C-12)
  • 免疫印迹; 人类; 1:1000; 图 3b
圣克鲁斯生物技术 DLC1抗体(Santa Cruz, sc-271915)被用于被用于免疫印迹在人类样品上浓度为1:1000 (图 3b). Oncol Lett (2017) ncbi
赛默飞世尔
兔 多克隆
  • 免疫组化-石蜡切片; 人类; 1:250; 图 2a
  • 免疫印迹; 人类; 图 4b
赛默飞世尔 DLC1抗体(Thermo Scientific, PA5-28443)被用于被用于免疫组化-石蜡切片在人类样品上浓度为1:250 (图 2a) 和 被用于免疫印迹在人类样品上 (图 4b). J Neurooncol (2016) ncbi
文章列表
  1. Wu Z, Li Y, Zhang G. Downregulation of microRNA-301a inhibited proliferation, migration and invasion of non-small cell lung cancer by directly targeting DLC1. Oncol Lett. 2017;14:6017-6023 pubmed 出版商
  2. Bujko M, Kober P, Rusetska N, Wakuła M, Goryca K, Grecka E, et al. Aberrant DNA methylation of alternative promoter of DLC1 isoform 1 in meningiomas. J Neurooncol. 2016;130:473-484 pubmed